WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility to Enhance Global CRDMO Services for Customers Kumar Jeetendra | September 10, 2022 SHANGHAI, Sept. 9, 2022– WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new sterile lipid nanoparticle (LNP) formulation development and manufacturing facility at its Wuxi city campus. Created in response to the increasing demand for complex injection dosage forms, this new facility adds to the company’s fast-growing parenteral formulation capabilities and is …
Unveiling the Top 10 CROs to Watch Out for in 2023 Kumar Jeetendra | September 5, 2023 Participants in clinical trials are volunteers helping scientists find treatments for specific medical issues. When carried out properly, they are the safest and quickest way to find new treatments and methods to improve people’s health. Medical professionals and scientists can learn more about diseases thanks to clinical research. With this knowledge, they can develop better …
